最新 100 件のみ表示中(全 3852 件)。 古い論文は Knowledge/ の MOC / Entity ページから辿れます。
2026-07-02 (5 papers)
- Xu et al. CancerCell 2026 — Received 24 february 2026 (Basic-Others)
- Wang et al. Carcinogenesis 2026 — Camrelizumab, apatinib and radiotherapy in locally advanced, unresectable (Basic-Others)
- Jong et al. JImmunotherCancer 2026 — Lenalidomide boosts CD1d-vdelta2 bispecific antibody-engaged Vgamma9Vdelta2-T cell effector functions via CD28, notch (Basic-Others)
- Poussaint et al. ClinCancerRes 2026 — And young adult patients with recurrent CNS tumors and newly-diagnosed DIPG (Clinical-Others)
- Fan et al. LancetOncol 2026 — Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases (Clinical-Others)
2026-07-01 (2 papers)
- Tian et al. NatBiomedEng 2026 — Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for duchenne muscular dystrophy (Basic-Extracellular vesicles)
- Goto et al. Nature 2024 — SOX17 enables immune evasion of early colorectal adenomas and cancers (Basic-Others)
2026-06-30 (9 papers)
- Li et al. CancerImmunolRes 2026 — Peripheral th17 immune signature associates with excellent response to anti-PD1anti-PD-L1 therapy across solid tumors (Basic-Others)
- Borghaei et al. ClinCancerRes 2026 — Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small … (Clinical-NSCLC-Driver negative)
- Okamoto et al. LungCancer 2026 — Durvalumab plus etoposide–platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC an… (Clinical-NSCLC-EGFR)
- Itchins et al. LungCancer 2026 — Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from t… (Clinical-NSCLC-ROS1)
- Abrahimi et al. JExpMed 2026 — Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models (Clinical-Novel modalities)
- Hofman et al. LungCancer 2026 — New biomarkers for antibody-drug conjugates in lung cancer the pathologist’s perspective (Clinical-Novel modalities)
- Cowzer et al. ClinCancerRes 2026 — Molecular and clinical determinants of targeted therapy treatment in biliary tract cancer (Clinical-Others)
- Medina et al. ClinCancerRes 2026 — AI-Based Pathology Classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A… (Clinical-Others)
- Mahmud et al. Oncologist 2026 — Biomarker testing patterns among patients newly diagnosed with metastatic non-small cell lung cancer, prostate cancer… (Clinical-Others)
2026-06-28 (11 papers)
- DiVizio et al. CancerRes 2009 — Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease (Basic-Extracellular vesicles)
- De et al. JExtracellVesicles 2026 — Characterizing the fate of anti-CS1 nanobody displaying extracellular vesicles in multiple myeloma (Basic-Extracellular vesicles)
- Ma et al. JExtracellVesicles 2026 — Enterococcus faecalis Extracellular Vesicles Deliver the Bacterial GTPase Obg to Hijack mTOR Signalling in Hepatocell… (Basic-Extracellular vesicles)
- Pegtel et al. ProcNatlAcadSciUSA 2010 — Functional delivery of viral miRNAs via exosomes (Basic-Extracellular vesicles)
- Routy et al. Science 2018 — Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors (Basic-Immunotherapy)
- Gabrilovich et al. NatRevImmunol 2012 — Coordinated regulation of myeloid cells by tumours (Basic-Neutrophil and myeloid cell)
review - Fuchs et al. ProcNatlAcadSciUSA 2010 — Extracellular DNA traps promote thrombosis (Basic-Neutrophil and myeloid cell)
- Nik-Zainal et al. Cell 2012 — Mutational Processes Molding the Genomes of 21 Breast Cancers (Basic-Others)
- Weickhardt et al. JThoracOncol 2012 — Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene… (Basic-Others)
- Shukla et al. NatBiotechnol 2015 — Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes (Basic-Others)
- Chu et al. NatCancer 2026 — Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and ther… (Clinical-Others)
2026-06-27 (19 papers)
- Zhu et al. JImmunotherCancer 2026 — Spatial immune atlas of breast cancer brain metastasis reveals CD163+ macrophage reprogramming associated with immune… (Basic-Brain metastasis)
- Wen et al. NatBiotechnol 2026 — Spatially resolved profiling of extracellular vesicles in tissues with spatial-EV-seq (Basic-Extracellular vesicles)
- George et al. CancerRes 2026 — Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8… (Basic-Immunotherapy)
- Wu et al. JImmunotherCancer 2026 — Sequential involvement of hypoxia and anti-PD-1 treatment in shaping tumor-regional CD39+ CD8+ T cells highlights imm… (Basic-Immunotherapy)
- Scaparone et al. CancerDiscov 2026 — EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling throug… (Basic-Oncogene and genetics)
- Gu et al. CancerRes 2026 — EGFR N-glycosylation catalyzed by NDST2 promotes lenvatinib resistance in hepatocellular carcinoma (Basic-Oncogene and genetics)
- Clarke et al. CancerRes 2026 — Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer (Basic-Others)
- Jiang et al. Cancers 2026 — Selective Inhibition of KRAS G13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant Ca… (Basic-Others)
- Repetto et al. ClinCancerRes 2026 — The genomic landscape of MYC, MYCL, and MYCN amplified solid tumors (Basic-Others)
- Abascal et al. JImmunotherCancer 2026 — FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-… (Basic-Others)
- De et al. NatMed 2026 — Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+/HER2- breast cancer: a randomize… (Basic-Others)
- Bashir et al. CancerCell 2026 — Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth (Basic-Tumor microenvironment)
- Liu et al. CancerCell 2026 — Molecular phenotypes and spatial archetypes A new framework for cancer-associated fibroblasts (Basic-Tumor microenvironment)
- Vujanovic et al. ClinCancerRes 2026 — Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with… (Clinical-NSCLC-Driver negative)
- Zamulko et al. ClinCancerRes 2026 — A phase 2 feasibility study combining pembrolizumab and metformin in patients with metastatic head and neck cancer (Clinical-NSCLC-Driver negative)
- Amor et al. Cell 2026 — CAR T targets AI takes the wheel (Clinical-Novel modalities)
- Baker et al. Cell 2026 — AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy (Clinical-Novel modalities)
- Li et al. MolCancer 2026 — Antibody-drug conjugates in breast cancer from mechanism to revolutionizing clinical practice (Clinical-Novel modalities)
- Trotta et al. Cell 2026 — Excessive vascular integrity restricts anti-tumor immunity (Clinical-SCLC)
2026-06-25 (17 papers)
- Wang et al. IntJBiolSci 2026 — USP33 Promotes Lung Adenocarcinoma Brain Metastasis by Inhibiting the K48-Linked Ubiquitination and Degradation of S1… (Basic-Brain metastasis)
- Cai et al. MolCancer 2026 — Extracellular vesicles in solid tumors from tumor ecology to engineered therapeutics (Basic-Extracellular vesicles)
review - Cai et al. JImmunotherCancer 2026 — Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA–IIIB non-small cell lung cancer: integrated multi… (Basic-Liquid-biopsy)
- Horndalsveen et al. JThoracOncol 2026 — ctDNA based MRD detection in stage III NSCLC treated with chemoradiotherapy and durvalumab (Basic-Liquid-biopsy)
- Osarogiagbon et al. AmSocClinOncolEducBook 2026 — Optimal use of targeted therapy and immunotherapy in early-stage, resectable non-small cell lung cancer (Basic-Others)
review - Marinello et al. CancerDiscov 2026 — Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer (Basic-Others)
- Zhu et al. CancerMed 2026 — Harnessing gut microbiota to enhance immunotherapy in NSCLC from mechanisms to translational applications (Basic-Others)
review - Zhang et al. JImmunotherCancer 2026 — HDAC inhibitors reverse YAP-driven immune resistance in NSCLC mechanistic and translational evidence (Basic-Others)
- Zhang et al. Nature 2026 — The mutational landscape of STING-induced immunity (Basic-Others)
- Chien et al. CancerImmunolImmunother 2026 — Smoking-associated modulation of gut microbiota shapes response to immune checkpoint inhibitors in non-small cell lun… (Clinical-NSCLC-Driver negative)
- Ulas et al. JImmunotherCancer 2026 — Rescue by Radiotherapy and Anti-CTLA4/PD-1 After Failure of Anti-PD-1 Therapy in Patients with Metastatic NSCLC: The … (Clinical-NSCLC-Driver negative)
- Lu et al. ClinLungCancer 2026 — Characteristics and Clinical Outcomes of De Novo and Acquired Uncommon Compound EGFR Mutations in Patients With Advan… (Clinical-NSCLC-EGFR)
- Garrido-Castro et al. AnnOncol 2026 — SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with meta… (Clinical-Novel modalities)
- Jee et al. CancerDiscov 2026 — Deconvolving SARS-CoV-2 mRNA vaccine impact on immunotherapy-related survival (Clinical-Novel modalities)
- Rohrberg et al. JImmunotherCancer 2026 — First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic so… (Clinical-Others)
- Roulleaux-Dugage et al. JImmunotherCancer 2026 — VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLC (Clinical-Others)
- Zhang et al. FrontImmunol 2026 — First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain meta… (Clinical-SCLC)
2026-06-24 (1 papers)
- Liu et al. ACSApplMaterInterfaces 2024 — Cell-specific impacts of surface coating composition on extracellular vesicle secretion (Basic-Extracellular vesicles)
2026-06-22 (3 papers)
- Morrissey et al. eLife 2018 — Chimeric antigen receptors that trigger phagocytosis (Basic-Immunotherapy)
- Hao et al. CellRepMed 2026 — Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative … (Basic-Neutrophil and myeloid cell)
- Klichinsky et al. NatBiotechnol 2020 — Human chimeric antigen receptor macrophages for cancer immunotherapy (Clinical-Novel modalities)
2026-06-21 (15 papers)
- Yue et al. Cell 2026 — Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy (Basic-Immunotherapy)
- Rys et al. TrendsCellBiol 2025 — Senescent neutrophils a hidden role in cancer progression (Basic-Neutrophil and myeloid cell)
review - Yiu et al. CancerDiscov 2026 — Same-Slide Spatial Multiomics Integration with IN-DEPTH Reveals Tumor Virus–Linked Spatial Reorganization of the Tumo… (Basic-Others)
- Ruggero et al. JClinInvest 2026 — Rewriting the cancer proteome: targeting selective translation as a therapeutic frontier (Basic-Others)
- Zhang et al. MolCell 2026 — PKCα-Mediated Nuclear Translocation of cGAS Stabilizes β-Catenin and Drives Metastasis (Basic-Others)
- Trapnell et al. NatBiotechnol 2014 — The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells (Basic-Others)
- Bray et al. NatBiotechnol 2016 — Near-optimal probabilistic RNA-seq quantification (Basic-Others)
- Aibar et al. NatMethods 2017 — SCENIC single-cell regulatory network inference and clustering (Basic-Others)
- Cohen et al. Science 2018 — Detection and localization of surgically resectable cancers with a multi-analyte blood test (Basic-Others)
- Takeuchi et al. ClinCancerRes 2009 — KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive L… (Clinical-NSCLC-ALK)
- Barbie et al. Nature 2009 — Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (Clinical-NSCLC-Driver-Other)
- Wu et al. NatRevImmunol 2026 — Programming the immunological properties of mRNA vaccines for cancer (Clinical-Novel modalities)
review - Larkin et al. NEnglJMed 2019 — Five-year survival with combined nivolumab and ipilimumab in advanced melanoma (Clinical-Others)
- Liu et al. NatRevMolCellBiol 2026 — Regulation and function of specialized membrane protrusions in intercellular communication (Clinical-Others)
review - Postow et al. NEnglJMed 2018 — Immune-related adverse events associated with immune checkpoint blockade (Clinical-irAE)
review
2026-06-20 (10 papers)
- Walther et al. JExtracellVesicles 2026 — Therapeutic poxviruses induce the secretion of immunostimulating and anti-tumoral extracellular vesicles (Basic-Extracellular vesicles)
- Lin et al. JImmunotherCancer 2026 — Integrin CD11b/CD18 Reprograms Macrophage Polarization by Suppressing ERK/STAT3 Signaling to Enhance Antitumor Immuni… (Basic-Neutrophil and myeloid cell)
- Liao et al. CancerCell 2026 — Targeting TROP2 in Drug-Tolerant Persister Cells Delays EGFR Tyrosine Kinase Inhibitor Resistance in Non-Small-Cell L… (Basic-Oncogene and genetics)
- Gan et al. AdvSci 2026 — Single-Cell Reveal GALNT7-Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non-Small C… (Basic-Others)
- Muneer et al. CancerLett 2026 — Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center … (Basic-Others)
- Strohbehn et al. JCOOncolPract 2026 — Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non–Small Cell Lung Cancer: A Propensity Score–Weighted … (Basic-Others)
- Dymun et al. SciTranslMed 2026 — Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous trans… (Basic-Others)
- Niu et al. FrontImmunol 2026 — Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer followi… (Clinical-NSCLC-EGFR)
review - Li et al. FrontImmunol 2026 — Effect of histology on the efficacy of first-line immune checkpoint inhibitors in advanced non-small cell lung cancer… (Clinical-Others)
review - Lovly et al. JCOPrecisOncol 2026 — Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non–Small C… (Clinical-Others)
2026-06-19 (8 papers)
- Sarni et al. NatGenet 2026 — A progeria syndrome links DNA hypermethylation to age-related pathology (Basic-Others)
- Ding et al. NatMed 2026 — Plasma proteomic signatures of cellular aging predict human disease (Basic-Others)
- Jiang et al. NatNanotechnol 2026 — Efficient prime editing in vivo and in vitro using lipid nanoparticles (Basic-Others)
- Gerhardt et al. Nature 2026 — Mutation-dependent responses to sleep and exercise in clonal haematopoiesis (Basic-Others)
- Menendez-Montes et al. Nature 2026 — Mitochondria directly interact with the nuclear pore complex (Basic-Others)
- Yue et al. Nature 2026 — Spatial distribution of the proteome in the human body and in cancers (Basic-Others)
- Tishina et al. NatCommun 2026 — Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis (Clinical-NSCLC-Driver-Other)
- Vishwanath et al. NatMed 2026 — General-purpose large language models outperform specialized clinical AI tools on medical benchmarks (Clinical-Others)